ArticleHealth science reports2026
Prevalence, Antimicrobial Resistance Profile, and Multidrug Resistance of Methicillin-Resistant
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Methicillin-resistant Methods: A cross-sectional, descriptive-analytic study was conducted over a 3-year period (January 2022-December 2024). The study population consisted of clinical specimens obtained from both inpatients and outpatients recorded at the Microbiology Laboratory. MRSA isolates were identified using standard microbiological techniques, and antimicrobial susceptibility testing was performed according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. The multidrug resistance (MDR) profile was determined based on resistance to at least three different antibiotic classes. Results: Among the clinical samples analyzed (279 Conclusion: The study highlights a notable prevalence of MRSA and MDR-MRSA among clinical isolates in Semarang, coupled with a concerning level of multidrug resistance. Although certain antibiotics remain effective against MRSA, the findings emphasize the necessity for continuous surveillance and antimicrobial stewardship programs. Strengthened infection control measures and optimized antibiotic management strategies are crucial to mitigating MRSA spread and preserving effective treatment options within Indonesian healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.